Treatment of Citrate Accumulation Using Continuous «CalciumFree» Hemodiafiltration in a Patient with Acute Kidney Injury Undergoing Cardiac Surgery

Regional citrate anticoagulation (RCA) is an increasingly common technique at continuous renal replacement therapy in critically ill patients with acute kidney injury (AKI). Regardless of the new anticoagulation protocols of RCA, citrate accumulation is remaining infrequent but unfavorable complication with poor outcome. Traditional treatment of this complication includes interruption of citrate administration, as well as increasing the
flow of blood and dialysate.

Objective: to evaluate safety and effects of a new modality, the continuous «calciumfree» hemodiafiltration, on electrolyte and acidbase status in a patient undergoing cardiac surgery with citrate accumulation after RCACRRT.

Materials and metods. Reduced level of calcium in the extracorporeal circuit has been achieved by applying calciumfree CiCa Dialysate K4 solution for predilution and dialysate. To prevent hypophosphatemia and hypomagne semia 500 ml/h Multiplus K+ solution was administered in a postdilution mode. Desired level (0.91.2 mmol/L) of ionized calcium was achieved by continuous infusion of 5% calcium chloride 612 ml/h into a separate central vein line.

Results. Although the target level (0.5mmol/l) of calcium after hemofilter was achieved only after 16 hours, the lifespan of the extracorporeal circuit was 23.5 hours. Total serum calcium decreased from 3.27 to 1.98 mmol/L. Other markers of acidbase balance had been fully normalized.

Conclusion. «Calciumfree» hemodiafiltration might be a promising treatment option for a citrate accumulation syndrome that ensures citrate removal and establishes satisfactory anticoagulation.

1. Kolesnikov S.V., Borisov A.S., Kornilov I.A., Lomivorotov V.V. Postoyannaya zamestitelnaya pochechnaya terapiya s ekstrakorporalnoi membrannoi oksigenatsiei v kardiokhirurgii. Obshchaya Reanimatologiya. [Continuous renal replacement therapy and extracorporeal membrane oxygenation in cardias surgery. General Reanimatology]. 2014; 10 (3): 75—84. http://dx.doi.org/10.15360/18139779201437584. [In Russ.]

2. Moroz G.B., Fominsky E.V., Shilova A.N., Karaskov A.M., Kornilov I.A., Pustovetova M.G., Lomivorotov V.V. Vliyanie tselenapravlennoi terapii razlichnymi infuzionnymi sredami na soderzhanie vnesosudistoi vodylegkikh u kardiokhirurgicheskikh bolnykh. Obshchaya Reanimatologiya. [Impact of goaloriented therapy with different infusion media on pulmonary extravascular water levels in cardiac surgery patients. General Reanimatology]. 2015; 11 (3): 54—64. http://dx.doi.org/10.15360/18139779201535464. [In Russ.]

3. Paromov K.V., Lenkin A.I., Kuzkov V.V., Kirov M.Yu. Tselenapravlennaya optimizatsiya gemodinamiki v perioperatsionnom periode: vozmozhnosti i perspektivy. [Goaloriented optimization of hemodynamics during perioperative period: opportunities and future perspectives]. Patologiya Krovoobrashcheniya i Kardiokhirurgiya. 2014; 3: 59—66. [In Russ.]

4. Hafner S., Stahl W., Fels T., Träger K., Georgieff M., Wepler M. Implementation of continuous renal replacement therapy with region al citrate anticoagulation on a surgical and trauma intensive care unit: impact on clinical and economic aspectsan observational study. J. Intensive Care. 2015; 3 (1): 35. http://dx.doi.org/10.1186/s4056001501027. PMID: 26229685

5. Stucker F., Ponte B., Tataw J., Martin P., Wozniak H., Pugin J., Saudan P. Efficacy and safety of citratebased anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit. Care. 2015; 19:91. http://dx.doi.org/10.1186/s130540150822z. PMID: 25881975

6. Shum H., Chan K., Yan W. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using Prismocitrate 10/2 solution. Ther. Apher. Dial. 2012; 16 (1): 81—86. http://dx.doi.org/10.1111/j.17449987.2011.01001.x. PMID: 22248200

7. Pouplard C., Regina S., May M., Gruel Y. Heparininduced thrombocy topenia: a frequent complication after cardiac surgery. Arch. Mal. Coeur. Vaiss. 2007; 100 (6—7): 563—568. PMID: 17893639

8. Davenport A., Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009; 2 (6): 439—447. http://dx.doi.org/10.1093/ndtplus/sfp136. PMID: 25949376

9. Nurmohamed S., Jallah B., Vervloet M., Yldirim G., ter Wee P., Groeneveld A. Continuous venovenoushaemofiltration with citratebuffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study. BMC Nephrol. 2013; 14: 89. http://dx.doi.org/10.1186/147123691489. PMID: 23597045

10. Link A., Klingele M., Speer T., Rbah R., Pöss J., Lerner-Gräber A., Fliser D., Böhm M. Totaltoionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit. Care. 2012; 16 (3): R97. http://dx.doi.org/10.1186/cc11363. PMID: 22643456

11. Khadzhynov D., Schelter C., Lieker I., Mika A., Staeck O., Neumayer H., Peters H., Slowinski T. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J. Crit. Care. 2014; 29 (2): 265—271. http://dx.doi.org/10.1016/j.jcrc.2013.10.015. PMID: 24360392